作者：
Leigh,Anderson [1]
;
Patrick,Antkowiak [1]
;
Aden,Asefa [1]
;
Amber,Ballard [1]
;
Tushar,Bansal [1]
;
Ayo,Bello [1]
;
Bernard,Berne [1]
;
Kristen,Bowsher [1]
;
Bennett,Blumenkopf [1]
;
Ian,Broverman [1]
;
Mohamad,Bydon [1]
;
Kuo,Chao [1]
;
Peter,Como [1]
;
Karlene,Cork [1]
;
Ann,Costello [1]
;
Kathryn,De Laurentis [1]
;
Angela,DeMarco [1]
;
Heather,Dean [1]
;
John,Doucet [1]
;
Bradley,Dworak [1]
;
Lisa,Epperson [1]
;
Eric,Franca [1]
;
Naz,Ghassemian [1]
;
Chandramallika,Ghosh [1]
;
Anupama,Govindarajan [1]
;
Jay,Gupta [1]
;
Stacie,Gutowski [1]
;
Robert,Herrmann [1]
;
Michael,Hoffmann [1]
;
William,Heetderks [1]
;
Steven,Hsu [1]
;
Daryl,Kaufman [1]
;
Erin,Keegan [1]
;
Gregg,Kittlesen [1]
;
Kevin,Khuu [1]
;
Hyung,Lee [1]
;
Larry,Lo [1]
;
Ian,Marcus [1]
;
Timothy,Marjenin [1]
;
Binoy,Mathews [1]
;
Sanjay,Misra [1]
;
Vivek,Pinto [1]
;
Vesper,Ramos [1]
;
Samuel,Raben [1]
;
Avena,Russell [1]
;
Devjani,Saha [1]
;
Joonil,Seog [1]
;
Christian,Shenouda [1]
;
Myra,Smith [1]
;
Xiaorui,Tang [1]
;
Kelliann,Wachrathit [1]
;
Jaime,Waterhouse [1]
;
Dhanya,Williams [1]
;
Xiaolin,Zheng [1]
;
Carlos,Peña [2]
作者单位：
Division of Neurological and Physical Medicine Devices, Office of Device Evaluation, Center for Devices and Radiological Health, United States Food and Drug Administration, Room 2680, Building 66, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
[1]
Division of Neurological and Physical Medicine Devices, Office of Device Evaluation, Center for Devices and Radiological Health, United States Food and Drug Administration, Room 2680, Building 66, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA. Electronic address: carlos.pena@fda.hhs.gov.
[2]
DOI
10.1016/j.neuron.2016.10.036
PMID
27930909
发布时间
2018-01-12
换一批
换一批
